Nuvalent (NUVL) Total Liabilities (2020 - 2026)

Nuvalent (NUVL) reported Total Liabilities of $156.8 million for Q1 2026, up 65.47% on a YoY basis from $94.7 million in Q1 2025, and down 4.61% quarter-over-quarter from $164.4 million in Q4 2025.

Nuvalent (NUVL) Total Liabilities (2020 - 2026) Analysis & Trends

Nuvalent has reported Total Liabilities for 7 years, with the latest figure at $156.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities rose 65.47% year-over-year to $156.8 million; the trailing twelve-month figure through Mar 2026 stood at $156.8 million (up 65.47% YoY), and the FY2025 full-year result was $164.4 million, up 128.41% from the prior year.
  • Total Liabilities for Q1 2026 stood at $156.8 million, down from $164.4 million in the prior quarter.
  • The five-year high for Total Liabilities was $164.4 million in Q4 2025, with the low at $8.1 million in Q1 2022.
  • Historically, Total Liabilities has averaged $59.5 million across 5 years, with a median of $33.4 million in 2024.
  • Annual changes were most pronounced in 2022 — Total Liabilities slumped 78.97% — and 2025, when it surged 183.45%.
  • Nuvalent's Total Liabilities stood at $19.5 million in 2022, then surged by 63.35% to $31.8 million in 2023, then surged by 126.13% to $72.0 million in 2024, then soared by 128.41% to $164.4 million in 2025, then decreased by 4.61% to $156.8 million in 2026.
  • The last three Total Liabilities figures came in at $156.8 million (Q1 2026), $164.4 million (Q4 2025), and $134.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 1.74 Mn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 15.48 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 16.35 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 731.60 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 19.51 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 10.44 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 943,068.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 7.12 Bn
9 Abivax 91.71 Bn 91.71 Bn - 137.56 Mn
10 Nuvalent 9.70 Bn 9.70 Bn - 156.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 156.78 Mn
Dec 31, 2025 164.37 Mn
Sep 30, 2025 134.51 Mn
Jun 30, 2025 100.80 Mn
Mar 31, 2025 94.75 Mn
Dec 31, 2024 71.96 Mn
Sep 30, 2024 67.73 Mn
Jun 30, 2024 38.19 Mn
Mar 31, 2024 33.43 Mn
Dec 31, 2023 31.82 Mn
Sep 30, 2023 29.10 Mn
Jun 30, 2023 20.80 Mn
Mar 31, 2023 17.02 Mn
Dec 31, 2022 19.48 Mn
Sep 30, 2022 12.98 Mn
Jun 30, 2022 10.04 Mn
Mar 31, 2022 8.12 Mn
Dec 31, 2021 8.79 Mn
Sep 30, 2021 6.84 Mn
Jun 30, 2021 5.83 Mn